» Articles » PMID: 35546268

Preclinical Assessment of OnabotulinumtoxinA for the Treatment of Mild Traumatic Brain Injury-related Acute and Persistent Post-traumatic Headache

Overview
Journal Cephalalgia
Specialties Neurology
Psychiatry
Date 2022 May 13
PMID 35546268
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Investigation of onabotulinumtoxinA in a murine model of acute and persistent post-traumatic headache.

Methods: Mild traumatic brain injury was induced with a weight drop method. Periorbital and hindpaw cutaneous allodynia were measured for 14 days. Mice were then exposed to bright light stress and allodynia was reassessed. OnabotulinumtoxinA (0.5 U) was injected subcutaneously over the cranial sutures at different post-injury time points.

Results: After milt traumatic brain injury, mice exhibited periorbital and hindpaw allodynia that lasted for approximately 14 days. Allodynia could be reinstated on days 14-67 by exposure to stress only in previously injured mice. OnabotulinumtoxinA administration at 2 h after mild traumatic brain injury fully blocked both transient acute and stress-induced allodynia up to day 67. When administered 72 h post-mild traumatic brain injury, onabotulinumtoxinA reversed acute allodynia, but only partially prevented stress-induced allodynia. OnabotulinumtoxinA administration at day 12, when initial allodynia was largely resolved, produced incomplete and transient prevention of stress-induced allodynia. The degree of acute allodynia correlated positively with subsequent stress-induced allodynia.

Conclusion: Mild traumatic brain injury induced transient headache-like pain followed by long lasting sensitization and persistent vulnerability to a normally innocuous stress stimulus, respectively modeling acute and persistent post-traumatic headache.. Administration of onabotulinumtoxinA following the resolution of acute post-traumatic headache diminished persistent post-traumatic headache but the effects were transient, suggesting that underlying persistent mild traumatic brain injury-induced maladaptations were not reversed. In contrast, early onabotulinumtoxinA administration fully blocked both acute post-traumatic headache as well as the transition to persistent post-traumatic headache suggesting prevention of neural adaptations that promote vulnerability to headache-like pain. Additionally, the degree of acute post-traumatic headache was predictive of risk of persistent post-traumatic headache.

Citing Articles

The Efficacy of Botulinum Toxin Use in Service Members and Veterans with Migraine and Post-Traumatic Headache Disorders: A Scoping Review.

Ruan Q, Pak D, Reece D, Jotwani R, Li S, Dominguez M J Pain Res. 2024; 17:4177-4186.

PMID: 39679425 PMC: 11646469. DOI: 10.2147/JPR.S487712.


Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?.

Pellesi L, Onan D, Martelletti P Toxins (Basel). 2024; 16(10).

PMID: 39453203 PMC: 11510946. DOI: 10.3390/toxins16100427.


Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache.

Rudolph M, Kopruszinski C, Wu C, Navratilova E, Schwedt T, Dodick D Cephalalgia. 2023; 43(11):3331024231217469.

PMID: 38016977 PMC: 11149587. DOI: 10.1177/03331024231217469.


Mechanisms and treatments of chronic pain after traumatic brain injury.

Chen Q, Bharadwaj V, Irvine K, Clark J Neurochem Int. 2023; 171:105630.

PMID: 37865340 PMC: 11790307. DOI: 10.1016/j.neuint.2023.105630.


Preclinical Studies of Posttraumatic Headache and the Potential Therapeutics.

Tanaka M, Zhang Y Cells. 2023; 12(1).

PMID: 36611947 PMC: 9818317. DOI: 10.3390/cells12010155.

References
1.
Ashina H, Porreca F, Anderson T, Amin F, Ashina M, Schytz H . Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol. 2019; 15(10):607-617. DOI: 10.1038/s41582-019-0243-8. View

2.
Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, Mezzaroma E . Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Neuroscience. 2010; 171(1):316-28. DOI: 10.1016/j.neuroscience.2010.08.067. View

3.
Goddeyne C, Nichols J, Wu C, Anderson T . Repetitive mild traumatic brain injury induces ventriculomegaly and cortical thinning in juvenile rats. J Neurophysiol. 2015; 113(9):3268-80. PMC: 4440238. DOI: 10.1152/jn.00970.2014. View

4.
Matak I, Bolcskei K, Bach-Rojecky L, Helyes Z . Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins (Basel). 2019; 11(8). PMC: 6723487. DOI: 10.3390/toxins11080459. View

5.
Burstein R, Yarnitsky D, Ransil B, Bajwa Z . An association between migraine and cutaneous allodynia. Ann Neurol. 2000; 47(5):614-24. View